Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,667,000 | 4,770,000 | 0 | 0 | 4,156,000 |
| Depreciation Amortization | 1,327,000 | 1,268,000 | 0 | 0 | 860,000 |
| Other Working Capital | 332,000 | 9,000 | 0 | 0 | -1,006,000 |
| Other Operating Activity | -1,583,000 | 14,000 | 0 | 0 | -248,000 |
| Operating Cash Flow | $6,743,000 | $6,061,000 | $0 | $0 | $3,762,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -723,000 | -1,296,000 | 0 | 0 | -1,538,000 |
| Net Acquisitions | 0 | 355,000 | 0 | 0 | 0 |
| Other Investing Activity | -459,000 | -1,320,000 | 0 | 0 | 367,000 |
| Investing Cash Flow | $-1,182,000 | $-2,261,000 | $0 | $0 | $-1,171,000 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,717,000 | 0 | 0 | 0 | 0 |
| Other Financing Activity | -2,855,000 | -2,287,000 | 0 | 0 | -959,000 |
| Financing Cash Flow | $-4,572,000 | $-2,287,000 | $0 | $0 | $-959,000 |
| Exchange Rate Effect | -21,000 | 34,000 | 0 | 0 | 0 |
| Beginning Cash Position | 3,927,000 | 0 | 0 | 0 | 0 |
| End Cash Position | 4,895,000 | 0 | 0 | 0 | 0 |
| Net Cash Flow | $968,000 | $444,000 | $0 | $0 | $-396,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,743,000 | 6,061,000 | 0 | 0 | 3,762,000 |
| Free Cash Flow | 6,743,000 | 6,061,000 | 0 | 0 | 3,762,000 |